Skye Bioscience Inc. (SKYE) at a glance

Skye Bioscience Inc. (SKYE) is a micro-cap Healthcare company. It trades at $0.71, with a P/E of 3.6 and a 0% profit margin. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Value (92/100) and its weakest is Momentum (14/100).

Price
$0.71
Market cap
$27.7M
P/E ratio
3.6
Dividend yield
None
Beta
n/a
52-week range
$0.57 to $5.75
Vestovix Score54/ 100How this works
Value
92
Growth
50
Income
40
Safety
46
Momentum
14

Other Healthcare stocks

See all